Category: health

 

Coronavirus live updates: Hospitalizations on the rise in 41 US states, analysis shows

Russia confirmed another 16,319 new cases of COVID-19 in the last 24 hours, its highest single-day tally yet.

It’s the first time since the start of the coronavirus pandemic that Russia’s daily case count has exceeded 16,000.

More than 30% of the newly confirmed cases — 4,999 — were reported in the capital, Moscow, according to Russia’s coronavirus response headquarters.

An additional 269 deaths from COVID-19 were also registered nationwide in the past 24 hours, just under last week’s peak of 286. The cumulative totals now stand at 1,431,635 cases and 24,635 deaths, according to Russia’s coronavirus response headquarters, which noted that the current growth rate in infections is 1.2%

Although Russia has been breaking its own records for daily case counts and deaths almost every day since Oct. 9, authorities there are resisting shutting down businesses again. Few measures have been imposed in Moscow, the epicenter of the country’s COVID-19 outbreak and recent surge.

The Eastern European country of 145 million people has the fourth-highest tally of COVID-19 cases in the world, behind only the United States, India and Brazil, according to a real-time count kept by Johns Hopkins University.

ABC News’ Alina Lobzina contributed to this report.

Source Article

Are Nursing Homes Safe Now? Kansas Facility Sees All Residents Test Positive For COVID-19

A Kansas nursing home has seen all 62 of its residents test positive for COVID-19 along with an unspecified number of staff members.

The coronavirus outbreak at the Norton County, Kansas-based Andbe Home nursing home resulted in the death of 10 residents and one hospitalization, with the remaining patients being treated at the facility, the Norton County Health Department confirmed on Monday night.

The health department said in a statement that the residents were being quarantined in their rooms and were not being allowed outside visitors.

Kansas has reported an average of more than 700 new positive cases of the coronavirus and probable cases of the virus a day – the largest reporting since early March, CBS News reported.

With the risk of contracting the coronavirus higher in elderly adults, many nursing homes are seeing cases spike as the pandemic continues to wage on. At the height of the outbreak at the Life Care Center nursing home in Kirkland, Washington, was an epicenter for the virus, with nearly two-thirds of its residents testing positive for the virus, KIRO, a Fox affiliate out of Seattle reported. At least 37 people died at the nursing home from the outbreak.

Just this week, a Rensselaer County nursing home in Texas reported that 10 residents tested positive for the virus, with 14 staff members also confirmed to have COVID-19, the Houston Chronicle reported.

A study in the journal JAMA indicated that while the coronavirus has a fatality rate of 1% to 2% overall, but in older patients in China, it was as high as 8% to 15%. The rapid spread of the coronavirus can make elderly adults more susceptible to the virus, which can cause more severe complications, NPR reported.

The news outlet also said that because elderly people have a reduced immune response, they become more vulnerable to spreading viruses such as the coronavirus. This becomes further complicated at nursing homes that are short-staffed and have personal protective equipment shortages, AARP said.

The U.S. has reported over 8.2 million positive cases of the coronavirus, with over 220,000 COVID-19 deaths, according to data from John Hopkins University.

Health workers -- from cleaning crews to doctors, in hospitals and nursing homes -- have been hit hard by the pandemic Health workers — from cleaning crews to doctors, in hospitals and nursing homes — have been hit hard by the pandemic Photo: AFP / Dimitar DILKOFF

Source Article

OSF names Rumph as president

ALTON — Jerry Rumph, MHA, FACHE, has been named the new president at OSF HealthCare Saint Anthony’s Health Center in Alton.

Rumph has a 25-year history in health care in the St. Louis area as well as military leadership that includes expertise in disaster planning and use of telemedicine for primary care. He will begin overseeing the day-to-day operations of OSF Saint Anthony’s and its other medical facilities in the Riverbend starting Nov. 16.

“Jerry brings a wealth of experience in everything from strategic planning to overseeing major capital improvements and growing services in communities where Mr. Rumph has served in leadership,” according to Sister M. Mikela Meidl, F.S.G.M., interim president Saint Anthony’s Health Center, executive vice president-chief ministry officer, OSF HealthCare.

“We are blessed to have someone with his breath of experience to advance our goal of expanding access to quality, affordable health care for residents throughout the Riverbend,” she said.


Rumph takes over as president of OSF Saint Anthony’s following the departure of Ajay Pathak. Most recently Rumph was chief executive officer for Mercy Rehabilitation Hospital in St. Louis. He also has served in a variety of leadership positions with SSM Health, a Catholic not-for-profit health system based in Missouri.

“I’m looking forward to bringing my collective experience to OSF Saint Anthony’s Health Center and collaborating with both the hospital staff and community leaders with the goal to continue providing exceptional care to families in the Alton and surrounding communities,” Rumph said.

Rumph has overseen and managed a $96 million hospital master facility plan and construction project that included the addition of three patient care floors on top of the existing hospital and new clinical service departments and clinics, which included a 35-bed rehabilitation facility that served as a hospital within a hospital.

As vice president of operations/chief operating officer at St Joseph Hospital-Lake St. Louis, his facility posted a consecutive hospital score in the 90th and 93rd percentile respectively for employee engagement, the highest scores of all 20 hospitals in SSM Health.

He also oversaw a $323,000 Telemedicine grant from the U.S. Army Medical Research and Development Command to create a trial of a virtual primary care clinic and created crisis plans for bioterrorism, chemical, and radiological disasters/attacks.

Rumph graduated from Northern Illinois University in DeKalb and earned a master’s degree in health care administration from Baylor University in Waco, Texas. He takes over as president of OSF Saint Anthony’s following the departure of Ajay Pathak.

OSF HealthCare is owned and operated by The Sisters of the Third Order of St. Francis, headquartered in Peoria. For more information visit osfhealthcare.org.

Source Article

Definition, risk factors, and how to overcome

“Suicidal tendencies” is a term that people sometimes use to describe someone who may be “at risk of suicide.” However, it is not a correct term, as suicide is not a characteristic that a person would have a “tendency toward.”

Someone who is at risk of suicide may be experiencing suicidal thoughts. These can range from vague thoughts of not wanting to exist anymore to being intentional about planning a way to end one’s own life.

Keep reading to learn more about risk factors for suicide and how to overcome them. We also provide some tips on coping with stress and depression.

Suicide prevention

If you know someone at immediate risk of self-harm, suicide, or hurting another person:

  • Ask the tough question: “Are you considering suicide?”
  • Listen to the person without judgment.
  • Call 911 or the local emergency number, or text TALK to 741741 to communicate with a trained crisis counselor.
  • Stay with the person until professional help arrives.
  • Try to remove any weapons, medications, or other potentially harmful objects.

If you or someone you know is having thoughts of suicide, a prevention hotline can help. The National Suicide Prevention Lifeline is available 24 hours per day at 800-273-8255. During a crisis, people who are hard of hearing can call 800-799-4889.

Click here for more links and local resources.

A growing amount of scientific evidence suggests that there may be a genetic link associated with suicide.

A 2012 meta-analysis examined people with a psychiatric diagnosis and noted that those with a certain gene variation had a greater risk of suicidal behavior.

Family studies also suggest some genetic involvement. Researchers who reviewed studies that explored this link highlighted an array of evidence suggesting that relatives of people who have attempted or died by suicide may be at a greater risk of death by suicide than relatives of those who have not.

However, what places a person at risk of suicidal thoughts or behavior is multifaceted. It likely involves an interaction among genetic factors, learned behaviors, and personal circumstances.

That said, it is extremely important to note that if a person has a family member who dies by suicide, it absolutely does not mean that they will too. The data above are purely statistical, and mental health is a complex issue that reaches far beyond the limits of statistical data.

Aside from a family history of suicide, there are many other potential risk factors that may lead to suicidal behavior. Suicide is strongly linked to depression. However, it is important to note that there is rarely one single cause of suicide.

According to the American Foundation for Suicide Prevention, risk factors for suicide may include:

Health-related factors

A variety of health conditions can increase a person’s risk of suicidal thoughts and behavior. These include:

  • mental health conditions
    • aggressive behavior, mood swings, and difficulty maintaining relationships
    • anxiety disorders
    • bipolar disorder
    • contact disorder
    • depression
    • problems with substance use
  • severe physical health conditions, such as pain
  • traumatic brain injury

Environmental factors

External influences that can

Todos Medical Receives Notices of Allowance From the European Patent Office Covering Use of TBIA Cancer Platform to Detect Benign Colon Cancer

NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Oct. 20, 2020 (GLOBE NEWSWIRE) — via NewMediaWire  Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has received a notice of allowance from the European Patent Office covering the use of the Company’s Total Biochemical Infrared Analysis (TBIA) platform to detect benign colon cancer in peripheral blood. The TBIA platform uses spectroscopy-based infrared analysis method to analyze immune cells in the blood or order to turn the biological information in the blood into data, and then mines that data using artificial intelligence to develop algorithms that are predictive of cancer and other diseases that impact the immune system, including bacteria and viruses. TBIA’s lead programs are in the detection of breast cancer and colon cancer.

“We are very pleased that we’ve received this notice of allowance for TBIA in benign tumors as it further adds to our market leading position as an AI-based cancer blood screening company,” said Gerald E. Commissiong, President & CEO of Todos Medical. “In particular, the method underlying this IP could be quite complementary to existing screening methods by adding additional information to help physicians distinguish between benign (polyps) and malignant tumors of the colon using a simple blood test. Taken in combination with some of our other patents and patent applications that cover the detection of malignant tumors of the colon, we believe we now have intellectual property that fully supports commercialization of our TBIA cancer platform for colon cancer.”

The global market for in vitro colorectal cancer (CRC) testing is estimated to reach $1.2 Billion by 2025, growing at a CAGR of 8.7% over the forecast period, driven by higher incidence and prevalence for colon and rectum cancers, colorectal polyps screening and improved treatment over the last few decades. Aging population and rising incidences of colorectal cancer, diabetes, inflammatory bowel disease, inherited syndrome, obesity, and smoking are some of the factors driving the in vitro CRC testing market. According to the American Cancer Society (2018), an estimated 135,430 people were diagnosed with colorectal cancer in the United States. The American Cancer Society’s estimates number of 95,520 new cases of colon cancer and 39,910 new cases of rectal cancer in the United States for 2017.

For information related to Todos Medical’s COVID-19 testing capabilities, please visit www.todoscovid19.com

For testing and PPE inquiries, please email [email protected]

About Todos Medical Ltd.

Headquartered in Rehovot, Israel, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic solutions for the early detection of a variety of cancers. The Company’s state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that deploys deep examination into cancer’s influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma. Todos’ two internally-developed cancer-screening tests, TMB-1 and TMB-2, have received a CE mark in Europe. Todos

Moderna Says COVID-19 Vaccine Could Be Ready As Soon As December With FDA Approval

KEY POINTS

  • Moderna CEO Stéphane Bancel says its COVID-19 vaccine could begin distribution as soon as December
  • Phase three trial delays could push distribution into early 2021.
  • Moderna expects to meet U.S. demand for the drug. It will also manufacture it in Switzerland for international distribution

Moderna says its COVID-19 vaccine could be ready for U.S. distribution as early as December.

Speaking at a Wall Street Journal tech conference, CEO Stéphane Bancel said Moderna expects interim results from phase three clinical trials by November, a timetable that could place an emergency approval from the FDA in December.

There are still some possible wrinkles, however: Moderna needs a minimum number of their 30,000 volunteers to contract COVID-19 before it can prove those without the vaccine were more likely to do so. Low infection rates could delay results.

If the results from that first population aren’t conclusive, Moderna would need to wait for a larger number of sick volunteers before seeking FDA approval. That would likely push a vaccine timetable into early 2021.

Hopes for a rapid vaccine faced a setback by the suspension of trials for two candidates Hopes for a rapid vaccine faced a setback by the suspension of trials for two candidates Photo: AFP / Ludovic MARIN

Last week vaccine competitor Pfizer said it would be seeking FDA approval in late November, as well, which would put its distribution date in December. Two other potential vaccines from Johnson & Johnson and AstraZeneca have their trials on hold pending investigations into unexplained illnesses among volunteers.

New FDA regulations require that vaccine developers wait two months from the last dose of their drug to prove long-term safety and efficacy. President Donald Trump fought their implementation, hoping to get a vaccine out before the November presidential election.

Both Pfizer and Moderna are set to clear this bar, with Moderna’s trials starting in July. It typically takes several weeks for the FDA to arrive at a decision once the drug is submitted, although if there was ever a drug that would be given extra resources it would be these.

Bancel said that Moderna projects it can produce 20 million doses in 2020, and 500 million in 2021. Moderna and its manufacturing partner, Lonza Ltd. say they will be able to meet U.S. demand. They will also be manufacturing the drug in Switzerland to distribute internationally.

Despite their expectations, Bancel said that manufacturing vaccines is a complex process with many moving parts that need to come together simultaneously.

“Unlike sometimes when you make a recipe at home, if you miss one ingredient, you might decide to still go ahead and make your meal,” he said, “In our case we cannot do that. We need all the ingredients to be there on time to be able to make a lot of vaccine.”

“If one ingredient is missing, we cannot make a vaccine.”

Source Article

Cosmetic Dyes Market to Reach $610.1 Mn, Globally, by 2026 at 4.9% CAGR: Allied Market Research

Surge in need for skin care products, increase in demand for natural ingredients in cosmetic products, and growing inclination for natural food ingredients and colorants drive the growth of the global cosmetic dyes market

PORTLAND, Ore., Oct. 20, 2020 /PRNewswire/ — Allied Market Research published a report, titled, Cosmetic Dyes Market by Product Type (Organic Dye and Inorganic Dye), and End User (Facial make up, Nail products, Eye make-up, Lip products, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026.” According to the report, the global cosmetic dyes industry was estimated at $420.3 million in 2018 and is anticipated to hit $610.1 million by 2026, registering a CAGR of 4.9% from 2019 to 2026.

Allied Market Research Logo
Allied Market Research Logo

Drivers, restraints, and opportunities-                                               

Surge in need for skin care products, increase in demand for natural ingredients in cosmetic products, and growing inclination for natural food ingredients and colorants drive the growth of the global cosmetic dyes market. On the other hand, several government regulations and increasing awareness about probable side effects of chemical based cosmetics impede the growth to some extent. Nevertheless, rise in demand for organic cosmetics and change in consumer preference for cost-effective cosmetics products are expected to create new opportunities in the industry.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6236

  • Covid-19 scenario-

  • The outbreak of the pandemic led to decline in demand for cosmetic products from individuals.

  • Also, disruptions in the supply chain and shortage in raw materials have negatively impacted the market.

  • However, with the existing regulations being eased off gradually in most of the countries, the market is expected to get back to its position soon.

The inorganic dyes segment to dominate by 2026-

Based on product type, the inorganic dyes segment contributed to nearlythree-fifths of the global cosmetic dyes market share in 2019 and is expected to lead the trail by 2026. The fact that inorganic pigments use chemical formulations to get the desired product properties for various applications drives the growth of the segment. The organic dyes segment, on the other hand, would register the fastest CAGR of 6.0% throughout the forecast period. This is attributed to the fact that organic cosmetics dyes are mostly handmade with natural organic ingredients like organic milk, and organic vegetable oils.

The facial make up segment to maintain the dominant share-

Based on application, the facial make up segment accounted for more than one-third of the global cosmetic dyes market revenue in 2019 and is anticipated to rule the roost till 2026. Manufacturers are working on to produce organic dyes for the facial make up products. This factor fuels the segment growth. Simultaneously, the nail products segment would portray the fastest CAGR of 6.3% by the end of 2026. Nail products such as creams and lotions are used to enhance the nails. And, rise in inclination toward enhanced products which give shine and better appearance when applied has driven the segment growth. Also, manufacturers are targeting the demand of customers by providing natural and organic dyes

Curbing COVID Brought Unexpected Benefit for Asthma Patients | Health News

By Robert Preidt, HealthDay Reporter

(HealthDay)

TUESDAY, Oct. 20, 2020 (HealthDay News) — Measures enacted to slow the spread of the new coronavirus also appeared to reduce hospitalizations for asthma, a new study finds.

Researchers compared weekly data on hospitalizations at 272 hospitals in Japan in the first five months of 2020 to the same period in 2017, 2018 and 2019.

Asthma hospitalizations in 2017-19 and 2020 showed similar trends until week eight, but in 2020 hospitalizations began to decline in week nine, the study found.

Hospitalizations for COVID-19 were first recorded during week seven of 2020. Further analysis found a significant decrease in the average number of asthma hospitalizations during weeks nine to 22 of this year compared to 2017-19.

The findings were published Oct. 13 in The Journal of Allergy and Clinical Immunology: In Practice.

“Asthma hospitalizations usually indicate that an individual’s asthma is not currently under control,” corresponding author Dr. Atsushi Miyawaki, of the University of Tokyo, said in a journal news release. “This would suggest that asthma control improved during the pandemic. It illustrates the importance of environmental factors when it comes to treating and managing patients with asthma.”

One possible explanation is that increased hygiene to prevent COVID-19 would also reduce exposure to asthma triggers, according to the researchers. Enhanced precautions — such as frequent cleaning and reduced smoking — by people concerned that COVID-19 may trigger asthma may also have helped reduce triggers.

Other possible explanations include people being more likely to use preventative asthma medications, and community COVID-19 prevention measures helping reduce other respiratory infections, which can cause worsen asthma.

The U.S. National Heart, Lung, and Blood Institute has more on asthma.

Copyright © 2020 HealthDay. All rights reserved.

Source Article

Man In Coma For 8 Years Wakes Up Minutes After Doctors Give Him Sleeping Pill

A man, who was in a coma for nearly a decade, regained full consciousness and started to walk, minutes after a doctor gave him a sleeping pill.

The man, identified as 37-year-old Richard, was hospitalized in his late 20s after he choked on a piece of meat which left him with severe brain damage. He suffered from akinetic mutism, a condition in which a person cannot move or speak.

After eight years, the doctors discovered that certain types of brain damage could be temporarily cured by sleeping pills. With his family’s permission, the pill, Zolpidem, was administered and within 20 minutes of taking it, the man woke up and also asked the nurse how he can operate the wheelchair.

“Because Richard’s situation seemed hopeless, the family and I decided to administer this medication to Richard. Against all expectations, Zolpidem had remarkable effects. After taking the sleeping pill, Richard started talking, wanted to call his father, and started recognizing his brothers again. With some help, he could even get up from his wheelchair and walk short distances,” Doctoral student Willemijn van Erp at Radboud University told medical journal Cortex. 

Speaking about the decision to give him the sleeping pill, Dr. Hisse Arnts at Amsterdam UMC said, “Richard’s brain scans show overactivity in certain parts of the brain. This overactivity causes noise and somehow shuts down the “good” brain activity. We have discovered that administering this sleeping medication can suppress this unwanted brain overactivity, creating space for speech and movement.”

The medication’s effect, however, started wearing off after it was administered once a day for five days.

“The time windows during which the patient was able to talk and move got narrower, and his abilities to move and speak during these time windows decreased. The use of multiple doses of zolpidem during a single day showed no improvement in his clinical condition and sometimes even caused sedation,” Dr. Arnts told the journal. 

CT scan This a representational image showing doctors looking at CT scan in Bethesda, Maryland, Feb. 8, 2018. Photo: SAUL LOEB/AFP/Getty Images

Source Article

CDC Recommends Face Masks in All Public Transportation Settings | Health News

By Robin Foster and E.J. Mundell
HealthDay Reporters

(HealthDay)

TUESDAY, Oct. 20, 2020 (HealthDay News) — Seeking to slow the spread of coronavirus, the U.S. Centers for Disease Control and Prevention recommended on Monday that face masks be worn by everyone in all public transportation settings.

That includes both passengers and people working in stations, terminals and airports across the country, CBS News reported.

So far, the Trump administration has not issued any national mandate on face coverings, instead leaving that decision to state and local leaders.

In the new interim guidance, the CDC called masks “one of the most effective strategies available for reducing COVID-19 transmission.” Wide use of masks helps protect those at higher risk of severe illness from COVID-19 as well as workers who frequently come into close contact with other people in airports, bus terminals, train stations and seaports, the guidance stated.

Most U.S. airlines, Amtrak and many other transport companies already require passengers and staff to wear masks, CBS News reported. The CDC urged passengers and workers on all airplanes, ships, ferries, trains, subways, buses, taxis and ride-shares to follow suit.

For months, research has shown that face masks help curb the spread of COVID-19. In the new guidance, the CDC said everyone “should wear masks that cover both the mouth and nose when waiting for, traveling on, or departing from public [transportation]. People should also wear masks at an airport, bus or ferry terminal, train or subway station, seaport, or similar area that provides transportation.”

The guidance also urges transport operators to “refuse boarding to anyone not wearing a mask and require all people onboard, whether passengers or employees, to wear masks for the duration of travel,” with exceptions for eating, drinking and medical disorders that prohibit mask wearing.

Reopened NYC schools not seeing surge in COVID cases

Three weeks after becoming the first big urban area to reopen public schools since the pandemic began, New York City is not seeing a feared surge in cases among students and staff.

Instead, health officials are seeing a surprisingly small number of COVID-19 cases, The New York Times reported.

Of the more than 15,000 staff members and students tested randomly in the first week of its testing regimen, the city has gotten back results for close to 11,000. There were only 18 positives: 13 staff members and five students, the Times reported. Even better, when officials put mobile testing units at schools near the Brooklyn and Queens neighborhoods that have had new outbreaks, only four positive cases surfaced in more than 3,300 tests conducted since the last week of September, the newspaper said.

New York City is facing fears of a second wave of the virus fueled by local spikes in Brooklyn and Queens, and official have closed more than 120 public schools as a precaution, the Times reported.

Still, the sprawling system of 1,800 public schools is a bright spot as the city tries to recover from a pandemic that has killed thousands and weakened